Neurological Biomarkers Are Situated In the Cerebral Spinal Fluid of the Body and Are Most of the Time Cannot Be Detected In Blood
Neurological
biomarkers are being researched and developed all over the world, including in
regions such as Germany, Mexico, and Japan. Neurological biomarkers are the
specific proteins in the cerebrospinal fluid (CSF) that can indicate the
presence of neurological disorders. They are mostly cross-functional and can be
found in many tissues throughout the body. Neurological biomarkers assist in
the diagnosis of nervous system disorders and monitor disease progression in
patients with neurological diseases. Neurological biomarkers are usually
expressed in a stepwise manner on cells. If these chemicals are found in high
concentration in a tissue, it indicates that it is involved in neurological
disease.
A
recent study has provided insights on the usage of neurological
biomarkers in Alzheimer's Disease. The researchers studied two sets of
elderly adults with Alzheimer's Disease. Surprisingly, the researchers found a
significantly higher prevalence of neurological biomarkers in Alzheimer's
Disease patients than in controls. Moreover, there is a significant association
between the abundance of these chemicals in the brain and the severity of
cognitive impairment in patients with Alzheimer's. In regions such a Germany,
the increasing prevalence of neurological disorders such as Alzheimer's has
increased the researches related to neurological biomarkers. For instance,
according to Alzheimer's Association, in Germany, over 1.5 million individuals
suffer from Alzheimer's disease.
The
neurological biomarkers market is showing tremendous potential for clinical
research and trials. The studies have been performed and are currently being
conducted to find the correlation between nutritional supplementation and
Alzheimer's Disease. The studies are also being performed to find the
usefulness of anti-oxidants in treating different neurological diseases. Most
importantly, more focus is being placed on the screening of normal biological
compounds, especially those which are within the pharynx, in order to determine
their toxicity when exposed to toxic substances. There are a number of possibly
toxic substances present in foods today that we consume unconsciously. The
neurological biomarkers market is providing a great service to medical science.
Although this market is rapidly growing, it is still lagging behind in terms of
availability. According to reports, there are still millions of people who are
affected by Alzheimer's Disease and are yet to be diagnosed or are experiencing
early-onset dementia.
Comments
Post a Comment